Ana Angulo

researcher

Ana Angulo is …
instance of (P31):
humanQ5

External links are
P9984CANTIC ID981058523888706706
P2798Loop ID468758
P496ORCID iD0000-0002-5792-1164
P11686University of Barcelona authority ID981058523888706706
P1580University of Barcelona authority ID (former scheme)a1389432
P214VIAF ID305870387

P69educated atComplutense University of MadridQ219694
Severo Ochoa Molecular Biology CenterQ20013983
P108employerUniversity of BarcelonaQ219615
Scripps ResearchQ793867
Institut d'Investigacions Biomèdiques August Pi i SunyerQ25422555
Severo Ochoa Molecular Biology CenterQ20013983
P734family nameAnguloQ21504529
AnguloQ21504529
AnguloQ21504529
P735given nameAnaQ482671
AnaQ482671
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q35347846A temporal gate for viral enhancers to co-opt Toll-like-receptor transcriptional activation pathways upon acute infection
Q34404551Ablation of the regulatory IE1 protein of murine cytomegalovirus alters in vivo pro-inflammatory TNF-alpha production during acute infection
Q38095771Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction
Q28550521An Interferon Regulated MicroRNA Provides Broad Cell-Intrinsic Antiviral Immunity through Multihit Host-Directed Targeting of the Sterol Pathway
Q34755471An essential role of the enhancer for murine cytomegalovirus in vivo growth and pathogenesis
Q57084132Characterization of the sequences of the human cytomegalovirus enhancer that mediate differential regulation by natural and synthetic retinoids
Q36493007Cutting edge: Ly9 (CD229), a SLAM family receptor, negatively regulates the development of thymic innate memory-like CD8+ T and invariant NKT cells.
Q27329902Cytomegalovirus m154 hinders CD48 cell-surface expression and promotes viral escape from host natural killer cell control
Q30322144Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice
Q33834411Dominance of virus over host factors in cross-species activation of human cytomegalovirus early gene expression
Q33788669Elimination of ie1 significantly attenuates murine cytomegalovirus virulence but does not alter replicative capacity in cell culture
Q33877530Enhancerless cytomegalovirus is capable of establishing a low-level maintenance infection in severely immunodeficient host tissues but fails in exponential growth.
Q40335295Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.
Q40207796Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus.
Q28477369Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis
Q39525113Human cytomegalovirus UL7, a homologue of the SLAM-family receptor CD229, impairs cytokine production
Q33800239Identification of a boundary domain adjacent to the potent human cytomegalovirus enhancer that represses transcription of the divergent UL127 promoter
Q39224323Immunoglobulin superfamily members encoded by viruses and their multiple roles in immune evasion.
Q52537275Impaired immunoproteasome assembly and immune responses in PA28-/- mice.
Q56169020Imprint of human cytomegalovirus infection on the NK cell receptor repertoire
Q36934017In vivo competence of murine cytomegalovirus under the control of the human cytomegalovirus major immediate-early enhancer in the establishment of latency and reactivation
Q28083186Infection homeostasis: implications for therapeutic and immune programming of metabolism in controlling infection
Q27486065Inhibition of African swine fever virus binding and infectivity by purified recombinant virus attachment protein p12
Q57200903Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infection
Q44130049Lymphotoxins and cytomegalovirus cooperatively induce interferon-beta, establishing host-virus détente.
Q36756335Mapping and sequence of the gene encoding the African swine fever virion protein of M(r) 11500.
Q40951265Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10.
Q36329073NK cell receptors involved in the response to human cytomegalovirus infection.
Q57200894NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies
Q35678024Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection.
Q57200899Natural killer cell-mediated response to human cytomegalovirus-infected macrophages is modulated by their functional polarization
Q36944091Neutrality of the canonical NF-kappaB-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro
Q36235786Novel Role of 3'UTR-Embedded Alu Elements as Facilitators of Processed Pseudogene Genesis and Host Gene Capture by Viral Genomes.
Q37073608Phenotypes of major immediate-early gene mutants of mouse cytomegalovirus.
Q33942045Principles of homeostasis in governing virus activation and latency.
Q46028688Regulation of human cytomegalovirus by retinoic acid.
Q38760564Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-kappaB binding sites in the enhancer
Q41737446Regulation of transporter associated with antigen processing by phosphorylation.
Q35840016Retinoid activation of retinoic acid receptors but not of retinoid X receptors promotes cellular differentiation and replication of human cytomegalovirus in embryonal cells
Q35382729Reversible inhibition of murine cytomegalovirus replication by gamma interferon (IFN-γ) in primary macrophages involves a primed type I IFN-signaling subnetwork for full establishment of an immediate-early antiviral state
Q36281793Signaling Lymphocytic Activation Molecule Family Receptor Homologs in New World Monkey Cytomegaloviruses
Q64078040Subversion of natural killer cell responses by a cytomegalovirus-encoded soluble CD48 decoy receptor
Q42779866Temporal profiling of the coding and noncoding murine cytomegalovirus transcriptomes
Q58198345The Magnitude of Interferon-γ Responses to Human Cytomegalovirus Is Predictive for HIV-1 Disease Progression
Q39627859The activator protein 1 binding motifs within the human cytomegalovirus major immediate-early enhancer are functionally redundant and act in a cooperative manner with the NF-{kappa}B sites during acute infection
Q37157169The mouse cytomegalovirus immediate-early 1 gene is not required for establishment of latency or for reactivation in the lungs
Q36567141The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response
Q40043683Transcriptional mapping of a late gene coding for the p12 attachment protein of African swine fever virus.
Q91804889Viral CD229 (Ly9) homologs as new manipulators of host immunity
Q35091211Viral enhancer mimicry of host innate-immune promoters
Q37991604Viral immunomodulatory proteins: usurping host genes as a survival strategy.
Q63345589Vitamin A Regulation of Viral Growth

Search more.